Cited 6 times in
Roadmap to resuming care for liver diseases after coronavirus disease-2019
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이혜원 | - |
dc.date.accessioned | 2021-09-29T01:34:47Z | - |
dc.date.available | 2021-09-29T01:34:47Z | - |
dc.date.issued | 2021-04 | - |
dc.identifier.issn | 0815-9319 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/184437 | - |
dc.description.abstract | The global pandemic of coronavirus disease-2019 (COVID-19) has led to significant disruptions in healthcare delivery. Patients with chronic liver diseases require a high level of care and are therefore particularly vulnerable to disruptions in medical services during COVID-19. Recent data have also identified chronic liver disease as an independent risk factor for COVID-19 related hospital mortality. In response to the pandemic, national and international societies have recommended interim changes to the management of patients with liver diseases. These modifications included the implementation of telehealth, postponement or cancelation of elective procedures, and other non-urgent patient care-related activities. There is concern that reduced access to diagnosis and treatment can also lead to increased morbidity in patients with liver diseases and we may witness a delayed surge of hospitalizations related to decompensated liver disease after the COVID-19 pandemic has receded. Therefore, it is paramount that liver practices craft a comprehensive plan for safe resumption of clinical operations while minimizing the risk of exposure to patients and health-care professionals. Here, we provide a broad roadmap for how to safely resume care for patients with chronic liver disease according to various phases of the pandemic with particular emphasis on outpatient care, liver transplantation, liver cancer care, and endoscopy. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Blackwell Scientific Publications | - |
dc.relation.isPartOf | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | COVID-19* / epidemiology | - |
dc.subject.MESH | COVID-19* / prevention & control | - |
dc.subject.MESH | Chronic Disease | - |
dc.subject.MESH | Delivery of Health Care* / methods | - |
dc.subject.MESH | Delivery of Health Care* / organization & administration | - |
dc.subject.MESH | Delivery of Health Care* / trends | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Infection Control* | - |
dc.subject.MESH | Liver Diseases* / epidemiology | - |
dc.subject.MESH | Liver Diseases* / therapy | - |
dc.subject.MESH | Organizational Innovation | - |
dc.subject.MESH | Patient Care Management* / methods | - |
dc.subject.MESH | Patient Care Management* / organization & administration | - |
dc.subject.MESH | Patient Care Management* / trends | - |
dc.subject.MESH | Risk Adjustment / methods* | - |
dc.subject.MESH | SARS-CoV-2 | - |
dc.title | Roadmap to resuming care for liver diseases after coronavirus disease-2019 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Devika Kapuria | - |
dc.contributor.googleauthor | Steven Bollipo | - |
dc.contributor.googleauthor | Atoosa Rabiee | - |
dc.contributor.googleauthor | Gil Ben-Yakov | - |
dc.contributor.googleauthor | Goutham Kumar | - |
dc.contributor.googleauthor | Keith Siau | - |
dc.contributor.googleauthor | Hye-Won Lee | - |
dc.contributor.googleauthor | Stephen Congly | - |
dc.contributor.googleauthor | Juan Turnes | - |
dc.contributor.googleauthor | Renumathy Dhanasekaran | - |
dc.contributor.googleauthor | Rashid N Lui | - |
dc.identifier.doi | 10.1111/jgh.15178 | - |
dc.contributor.localId | A03318 | - |
dc.relation.journalcode | J01417 | - |
dc.identifier.eissn | 1440-1746 | - |
dc.identifier.pmid | 32656794 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | Chronic liver disease | - |
dc.subject.keyword | Endoscopy | - |
dc.subject.keyword | Hepatocellular carcinoma | - |
dc.subject.keyword | Hepatology | - |
dc.subject.keyword | Liver transplantation | - |
dc.subject.keyword | Outpatient | - |
dc.subject.keyword | Post-pandemic | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.contributor.alternativeName | Lee, Hye Won | - |
dc.contributor.affiliatedAuthor | 이혜원 | - |
dc.citation.volume | 36 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 885 | - |
dc.citation.endPage | 892 | - |
dc.identifier.bibliographicCitation | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.36(4) : 885-892, 2021-04 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.